Shelter Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 26/06/2025 to consider, approve and to raise funds by way of issue of Convertible Equity Warrants convertible into the Equity Shares of face value of Rs 10 each of the Company, the proposed Allottees of such Warrants, Number of Warrants, Issue Price and other relevant details relation to Warrants, by way of Preferential Issue and Private Placement in one or more tranches, subject to applicable law and requisite approvals including approval of the Shareholders of the Company, Government / Regulatory / Statutory approvals, as may be applicable.
The above information is a part of company’s filings submitted to BSE.
